Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors influencing the outcomes of non-pharmacological interventions for managing fatigue across the lifespan of people living with musculoskeletal (MSK) conditions: a scoping review protocol.
Fishpool K, Young G, Ciurtin C, Cramp F, Erhieyovwe EO, Farisogullari B, Macfarlane GJ, Machado PM, Pearson J, Santos E, Dures E. Fishpool K, et al. Among authors: farisogullari b. BMJ Open. 2024 May 3;14(5):e082555. doi: 10.1136/bmjopen-2023-082555. BMJ Open. 2024. PMID: 38702081 Free PMC article. Review.
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study.
Di Matteo A, Smerilli G, Di Donato S, Liu AR, Becciolini A, Camarda F, Cazenave T, Cipolletta E, Corradini D, de Agustín JJ, Destro Castaniti GM, Di Donato E, Di Geso L, Duran E, Farisogullari B, Fornaro M, Francioso F, Giorgis P, Granel A, Hernández-Díaz C, Horvath R, Hurnakova J, Jesus D, Karadag O, Li L, Marin J, Martire MV, Michelena X, Moscioni E, Muntean L, Piga M, Rosemffet M, Rovisco J, Sahin D, Salaffi F, Saraiva L, Scioscia C, Tamas MM, Tanimura S, Venetsanopoulou A, Ventura-Rios L, Villota O, Villota-Eraso C, Voulgari PV, Vukatana G, Zacariaz Hereter J, Marzo-Ortega H, Grassi W, Filippucci E. Di Matteo A, et al. Among authors: farisogullari b. Ann Rheum Dis. 2024 Mar 5:ard-2023-225443. doi: 10.1136/ard-2023-225443. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38443140
Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.
Temiz Karadağ D, Komac A, Erez Y, Birlik AM, Sari A, Akdoğan A, Farisogullari B, Kimyon G, Koc E, Arslan D, Karatas A, Koca SS, Kasifoglu N, Yazici A, Hayran KM, Cefle A. Temiz Karadağ D, et al. Among authors: farisogullari b. Immun Inflamm Dis. 2023 Dec;11(12):e1089. doi: 10.1002/iid3.1089. Immun Inflamm Dis. 2023. PMID: 38134320 Free PMC article.
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates.
Sandal Uzun G, Taghiyeva A, Çakır İY, Moral K, Yardımcı GK, Bölek EÇ, Farisoğulları B, Duran E, Ayan G, Özsoy Z, Ekici M, Unaldı E, Germe ŞA, Fırlatan B, Kart-Bayram GS, Bilgin E, Kılıç L, Karadağ Ö, Akdoğan A, Bilgen ŞA, Kiraz S, Ertenli AI, Kalyoncu U. Sandal Uzun G, et al. Among authors: farisogullari b. Int J Rheum Dis. 2024 Jan;27(1):e14967. doi: 10.1111/1756-185X.14967. Epub 2023 Dec 6. Int J Rheum Dis. 2024. PMID: 38057290
Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Farisogullari B, Santos EJF, Dures E, Geenen R, Machado PM; EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases; EULAR taskforce on Recommendations for the management of fatigue in people withinflammatory rheumatic diseases. Farisogullari B, et al. RMD Open. 2023 Dec 6;9(4):e003349. doi: 10.1136/rmdopen-2023-003349. RMD Open. 2023. PMID: 38056919 Free PMC article.
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Dures E, Farisoğulları B, Santos EJF, Molto A, Feldthusen C, Harris C, Elling-Audersch C, Connolly D, Elefante E, Estévez-López F, Bini I, Primdahl J, Hoeper K, Urban M, van de Laar MAFJ, Redondo M, Böhm P, Amarnani R, Hayward R, Geenen R, Rednic S, Pettersson S, Thomsen T, Uhlig T, Ritschl V, Machado PM. Dures E, et al. Among authors: farisogullari b. Ann Rheum Dis. 2023 Nov 22:ard-2023-224514. doi: 10.1136/ard-2023-224514. Online ahead of print. Ann Rheum Dis. 2023. PMID: 38050029
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.
Karadag O, Farisogullari B, Yagiz B, Erden A, Ademoglu Z, Kimyon G, Bilge NS, Icacan OC, Kilic L, Coskun BN, Ersozlu ED, Kucuksahin O, Mercan R, Koca SS, Gonullu E, Cinar M, Akar S, Emmungil H, Kasifoglu T, Bes C, Omma A, Pehlivan Y, Kiraz S, Ertenli I, Dalkilic E, Kalyoncu U. Karadag O, et al. Among authors: farisogullari b. Clin Exp Rheumatol. 2024 Jan;42(1):130-137. doi: 10.55563/clinexprheumatol/2h6ma1. Epub 2023 Aug 29. Clin Exp Rheumatol. 2024. PMID: 37650346 Free article.
Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Santos EJF, Farisogullari B, Dures E, Geenen R, Machado PM; EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases. Santos EJF, et al. Among authors: farisogullari b. RMD Open. 2023 Aug;9(3):e003350. doi: 10.1136/rmdopen-2023-003350. RMD Open. 2023. PMID: 37604639 Free PMC article.
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry.
Duran E, Ozturk ZO, Bilgin E, Büyükaşık Y, Dizdar O, Yardimci GK, Farisogullari B, Özsoy Z, Ayan G, Uzun GS, Ekici M, Unaldi E, Kilic L, Akdoğan A, Karadag O, Bilgen ŞA, Kiraz S, Kalyoncu U, Ertenli AI. Duran E, et al. Among authors: farisogullari b. Rheumatol Ther. 2023 Aug;10(4):969-981. doi: 10.1007/s40744-023-00563-z. Epub 2023 Jun 9. Rheumatol Ther. 2023. PMID: 37294405 Free PMC article.
27 results